International Cosmetic Ingredient Nomenclature Committee (INC)

Personal Care Products Council / Resources / INCI / International Cosmetic Ingredient Nomenclature Committee (INC)

International Cosmetic Ingredient Nomenclature Committee (INC)

The International Cosmetic Ingredient Nomenclature Committee (INC), sponsored by PCPC, is comprised of dedicated scientists from industry, academia, regulatory authorities and sister associations who volunteer their time to serve the global cosmetics industry community.

The INC is charged with the responsibility of designating INCI names. INCI names are uniform, systematic names internationally recognized to identify cosmetic ingredients. In the United States and many countries around the world, INCI names are referenced by regulation for ingredient labeling cosmetic products. As part of the process of coining INCI names, the INC oversees the continued development of the INCI nomenclature system and assures the integrity of the information related to INCI names that is published in the International Cosmetic Ingredient Dictionary and Handbook.

Members of the INC convene approximately five times a year for two-day sessions to review applications for new INCI names and petitions for INCI name changes. Applications are addressed in date order, and INCI names are designated on a consensus basis in accordance with the conventions developed since the nomenclature effort was initiated in the 1970s. The INC also participates in web-based conferencing to review monograph development for INCI names. Additionally, the INC responds to other matters related to The Dictionary, nomenclature development and international nomenclature harmonization.

Members

  • Mike Fevola, Ph.D., Inolex, Chairman
  • Aaron Brown, Ph.D., Stepan, Vice-Chair
  • Eric Abrutyn, consultant
  • Jim Anderson, consultant
  • Agustina Gentile, Ph.D., Unilever
  • Mindy Goldstein, Ph.D., consultant
  • Euen Gunn, Vogue Int’l
  • Greg Hillebrand, Ph.D., University of Cincinnati
  • Jolanta Idkowiak-Baldys, Ph.D., L’Oreal
  • Laurie Joseph, Ph.D., Rutgers, The State University of New Jersey
  • Robert Lochhead, Ph.D., University of Southern Mississippi
  • Alexander Lorestani, Ph.D., Geltor, Inc
  • Shawn McConaughy, Ph.D., P&G
  • Stanley Milstein, Ph.D., consultant
  • Dan Nowlan, Ph.D., Estee Lauder Companies
  • John Sanzone, consultant
  • Mike Starch, consultant
  • David Story, Kao Brands
  • Krishnan Tamaraselvy, Ph.D., Lubrizol
  • Willem van der Wilden, Ph.D., consultant
  • Bart Heldreth, Ph.D., Cosmetic Ingredient Review
  • Georgios Manikas, Ph.D., European Commission
  • Mu Min, CAFFCI
  • Stephanie Shubat, U.S. Adopted Names Council
  • Ryuji Sugai, Japan Cosmetic Industry Association
  • Colleen Sutton, Ph.D., Health Canada
  • Rajeshwar Verma, Ph.D., U.S. Food & Drug Administration
  • Steven Wolfgang, Ph.D, U.S. Food & Drug Administration
  • Joanne Nikitakis, PCPC
  • Alex Peterson, Ph.D., PCPC
  • Oluwaseyitan Owoeye, PCPC

Teams

Biotech Subcommittee

  • Mindy Goldstein, Chair
  • Agustina Gentile
  • Alex Lorestani
  • John Sanzone
  • Ryuji Sugai
  • Laurie Joseph
  • Wim van der Wilden
  • Anne Young
  • Jim Anderson, Chair
  • Aaron Brown
  • Eric Abrutyn
  • Euen Gunn
  • Dan Nowlan
  • Dave Story
  • Steve Wolfgang
  • Mike Starch, Chair
  • Eric Abrutyn
  • Mike Fevola
  • Hubert Lam
  • Bob Lochhead
  • Shawn McConaughy
  • KT Selvy